RaySearch Laboratories AB (publ)

Stockholm Stock Exchange RAY-B.ST

RaySearch Laboratories AB (publ) Dividend Per Share for the year ending December 31, 2023: USD -0.00

RaySearch Laboratories AB (publ) Dividend Per Share is USD -0.00 for the year ending December 31, 2023, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.
  • RaySearch Laboratories AB (publ) Dividend Per Share for the year ending December 31, 2022 was USD -0.00, a 0.00% change year over year.
  • RaySearch Laboratories AB (publ) Dividend Per Share for the year ending December 31, 2021 was USD -0.00, a 0.00% change year over year.
  • RaySearch Laboratories AB (publ) Dividend Per Share for the year ending December 31, 2020 was USD -0.00, a 0.00% change year over year.
  • RaySearch Laboratories AB (publ) Dividend Per Share for the year ending December 31, 2019 was USD -0.00, a 0.00% change year over year.
Key data
Date Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE)
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: RAY-B.ST

RaySearch Laboratories AB (publ)

Description

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.

Similar companies

BIOT.ST

Biotage AB (publ)

USD 12.37

-2.86%

VITR.ST

Vitrolife AB (publ)

USD 19.80

-1.20%

PROB.ST

Probi AB (publ)

USD 31.05

0.32%

EKTA-B.ST

Elekta AB (publ)

USD 5.73

-2.84%

CEVI.ST

CellaVision AB (publ)

USD 19.20

-5.48%

StockViz Staff

February 4, 2025

Any question? Send us an email